Clinical Trial Update: Glutide for Ending Methamphetamine [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of Glutide for methamphetamine dependence is not yet recruiting, with the San Francisco Department of Public Health listed as sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Dependence

Drugs mentioned

• Glutide (glutide)

Snippet

Sponsor: San Francisco Department of Public Health | Conditions: Methamphetamine-dependence | Phase 2 | Status: NOT_YET_RECRUITING